Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals thyroid function screening's importance in PCOS management, indicating metabolic risks.
SCH is a common and metabolically relevant comorbidity in women with PCOS, aggravating insulin resistance and dyslipi-demia without significantly affecting reproductive hormones. These findings highlight the need for routine thyroid function screening in PCOS management, especially among those with metabolic syndrome features. Further longitudinal studies are warranted to evaluate the benefits of targeted thyroid intervention in this subgroup.
No takes yet. Share an insight, caveat, or question.
Acharya et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: